Skip to content

A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes

A Psychological-behavioral Intervention for Physical Activity in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03150199
Acronym
BEHOLD-8
Enrollment
60
Registered
2017-05-12
Start date
2017-07-25
Completion date
2019-10-10
Last updated
2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes

Brief summary

The focus of this study is to examine the feasibility, acceptability, and impact of a customized, combined positive psychology and motivational interviewing (PP-MI) health behavior intervention versus a motivational interviewing (MI) health education intervention in a group of patients with type 2 diabetes (T2D).

Detailed description

The investigators will compare a combined positive psychology and motivational interviewing (PP-MI) intervention that is adapted for patients with T2D to a motivational interviewing (MI) health education intervention. The MGH Diabetes Center and MGH primary care clinics will serve as the source of subjects for the study, with patients who have a diagnosis of T2D serving as potential participants. The investigators will enroll 60 participants, who will be randomized to either an 8-week PP-MI health behavior intervention or an 8-week MI-based health education intervention. In this project, the investigators plan to do the following: 1. Examine the feasibility and acceptability of an 8-week, telephone-delivered health behavior intervention utilizing PP exercises and MI with systematic goal-setting. 2. Determine whether the PP-MI intervention leads to greater increases in physical activity than the MI-based education intervention in T2D patients. 3. Explore the impact of the PP-MI intervention on other psychological, behavioral, and medical outcomes, compared to the MI-based education intervention. Participants will undergo an initial screening visit during which they will meet with study staff in person. At this visit, study eligibility will be confirmed, and eligible and willing participants will be enrolled. Following enrollment, participants will complete self-report measures, and vital signs and A1c will be measured. They then will take home and wear an accelerometer for one week, to measure baseline physical activity. Baseline information about enrolled participants will be obtained from the patients, care providers, and the electronic medical record as required for characterization of the population. This information will include data regarding medical history (type 2 diabetes mellitus), current medical variables (conditions affecting physical activity), medications, and sociodemographic data (age, gender, race/ethnicity, living alone). Participants will undergo a second in-person visit once adequate baseline physical activity data has been obtained. In this visit, accelerometer data will be reviewed to ensure that adequate baseline activity was captured. If so, participants will be randomized to either the PP-MI or MI-based health education intervention, then begin the study intervention. During this second in-person visit, participants will receive either a PP-MI or MI-based health education treatment manual, depending on randomization. For the PP-MI intervention: For each session, a PP exercise will be described in the manual, with instructions and space to write about the exercise and its effects. Next, an MI section will outline specific MI-based topics (e.g., pros/cons, managing slips) and facilitate physical activity goal-setting. At subsequent sessions, participants will review the prior week's PP exercise and learn about a new exercise, then will review the prior week's physical activity goal and set a new one. For the MI-based health education intervention: Each week, participants will learn about a different health behavior topic related to diabetes health. They will also be introduced to motivational interviewing topics in concert with the health behavior education topics, including medication adherence, having a heart-healthy diet, and being physically active. Participants will complete the remaining sessions by phone approximately weekly over the next 8 weeks. Phone sessions will last approximately 30 minutes, with PP-MI and physical activity assignments completed between phone sessions. PP and MI components will be delivered step-wise within sessions (rather than intertwined) based on our experience, participant feedback, and pilot work. If a week is missed, the session will not be skipped, but rather the intervention will be completed sequentially (with participants who miss weeks then missing the final sessions), with the exception of the final call, which skips to Planning for the Future in all cases. Participants will undergo an in-person follow-up assessment at 8 weeks. At this session, participants will repeat self-report assessments that were administered at baseline. Vital signs and a blood sample will again be collected at this in-person visit. Prior to this assessment, participants will wear an accelerometer for an additional 7 days to measure physical activity. Participants will also undergo a phone follow-up assessment at 16 weeks. During this session over the phone, participants will repeat self-report assessments that were administered at baseline. Finally, prior to this follow-up, participants will wear another accelerometer for 7 days to measure physical activity.

Interventions

Participants randomized to PP-MI will receive a treatment manual. For each session, a PP exercise will be described in the manual, with instruments and space to write about the exercise and its effects. Next, an MI section will outline specific MI-based topics (e.g., pros/cons, managing slips) and facilitate physical activity goal-setting. Following randomization, participants will engage in weekly, 30-minute phone calls over the next 8 weeks. Participants will independently complete PP exercises and MI-based goals between phone sessions and review them during phone sessions. PP and MI components will be delivered step-wise within sessions (rather than intertwined).

BEHAVIORALMI-based Health Education Intervention

Each week, participants will learn about a different health behavior topic related to diabetes health. As an attentional control, this condition has a parallel structure to the experimental arm with a treatment manual, weekly assignments, and weekly calls to review assignments. Motivational interviewing topics (e.g., pros and cons of behavior change, importance and confidence of behavior change, identification of barriers and resources to change) will be presented related to each health behavior.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. T2D. Eligible patients will meet American Diabetes Association (ADA) criteria for T2D (e.g., HbA1c \[A1C\] ≥6.5%, fasting glucose ≥126 mg/d), with diagnosis confirmed by their diabetes clinician and/or medical record review. 2. Low physical activity. Low physical activity will be defined as ≤150 minutes/week of MVPA (corresponding to ADA recommendations for moderate or greater intensity aerobic physical activity). Physical activity will be measured using a brief questionnaire adapted from the International Physical Activity Questionnaire (IPAQ).

Exclusion criteria

1. Cognitive impairment precluding consent or meaningful participation. 2. Lack of phone availability. 3. Inability to read/write in English. 4. Additional medical conditions (e.g., severe arthritis) that preclude physical activity. 5. Enrollment in mind-body programs, lifestyle intervention programs (e.g., cardiac rehabilitation), or other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Number of PP-MI Sessions Completed by Participants8 weeksMeasured by number of PP-MI sessions completed by participants in the PP-MI group.

Secondary

MeasureTime frameDescription
Utility of MI ComponentWeeks 1-8Participants in the PP-MI group will provide ratings of utility after each MI exercise, measured on a 10-point Likert scale (0=not at all helpful; 10=very helpful). Weekly utility ratings were averaged to provide an overall utility score of the exercises.
Change in Sedentary TimeChange from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by Actigraph accelerometer, in minutes per day.
Change in Positive AffectChange in score from Baseline to 8 weeks, and Baseline to 16 weeksThe positive affect items on the Positive and Negative Affect Schedule (PANAS), a well-validated scale used in other intervention trials and in patients with medical illnesses, will be used to measure positive affect (Range: 10-50). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of positive affect.
Change in OptimismChange in score from Baseline to 8 weeks, and Baseline to 16 weeksLife Orientation Test-Revised is a well-validated 6-item instrument used to measure dispositional optimism (Range: 0-24). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of optimism.
Change in Self-Efficacy for ExerciseChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the Self-Efficacy for Exercise scale (SEE), a validated scale which assess self-efficacy barriers to exercise (Range: 0-90). Higher scores indicate higher efficacy expectations in relation to exercising. This was measured at Baseline, Week 8, and Week 16.
Change in DepressionChange in score from Baseline to 8 weeks, and Baseline to 16 weeksThe Hospital Anxiety and Depression Scale (HADS)-depression subscale was be used to measure depression. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of depression.
Change in AnxietyChange in score from Baseline to 8 weeks, and Baseline to 16 weeksThe Hospital Anxiety and Depression Scale (HADS)-anxiety subscale was be used to measure anxiety. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of anxiety.
Change in ResilienceChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the Brief Resilience Scale (BRS), a reliable scale which assesses a person's ability to recover from stress despite adversity (Range: 6-30). Higher scores indicate more resilience.
Change in Perceived Social SupportChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the Multidimensional Scale of Perceived Social Support (MSPSS), a scale that measures subjectively reported social support (Range: 12-84). Higher scores indicate more subjectively reported social support.
Change in Diabetes Self-CareChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the Summary of Diabetes Self-Care Activities (SDSCA), a well-validated measure of diabetes self-management that is associated with clinical outcomes (Range: 0-7). Higher scores indicate more diabetes self-care activities.
Ease of PP ComponentWeeks 1-8Participants in the PP-MI group will provide ratings of ease after each PP exercise, measured on a 10-point Likert scale (0=very difficult; 10=very easy). Weekly ratings were averaged to provide an overall ease of the exercises.
Ease of MI ComponentWeeks 1-8Participants in the PP-MI group will provide ratings of ease after each MI exercise, measured on a 10-point Likert scale (0=very difficult; 10=very easy). Weekly ratings were averaged to provide an overall ease of the exercises.
Utility of PP ComponentWeeks 1-8Participants in the PP-MI group will provide ratings of utility after each PP exercise, measured on a 10-point Likert scale (0=not at all helpful; 10=very helpful). Weekly utility ratings were averaged to provide an overall utility score of the exercises.
Change in Moderate-Vigorous Physical ActivityChange from Baseline to 8 weeks, and Baseline to 16 weeksActiGraph GT3X+ step counters are validated as measures of physical activity and have been used in numerous studies of physical activity in patients with medical illness. In this trial, participants will wear the accelerometer for one week at baseline, 8 weeks, and 16 weeks to assess the feasibility of doing so and to ensure adequate capture of physical activity.
Change in Physical ActivityChange from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by Actigraph accelerometer, in number of steps per day.

Other

MeasureTime frameDescription
Change in Physical FunctionChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the 20-item short form of the Patient-Reported Outcomes Measurement Information System (PROMIS), a well-validated measure of physical function that is highly responsive to changes in a patient's physical function status (Range: 20-100). Higher scores indicate better physical function.
Change in Pain-Related DisabilityChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the Pain Disability Index (PDI), a well-validated measure of the extent to which pain interferes with different daily activities (Range 0-70). Higher scores indicate greater interference from pain.
Change in WeightChange from Baseline to Week 8Measured during in-person visit at baseline and post-intervention.
Change in Body Mass Index (BMI)Change from Baseline to Week 8Measured during in-person visit at baseline and post-intervention.
Change in Blood Pressure (Systolic)Change from Baseline to Week 8Measured during in-person visit at baseline and post-intervention.
Change in Blood Pressure (Diastolic)Change from Baseline to Week 8Measured during in-person visit at baseline and post-intervention.
Change in Hemoglobin A1cChange from Baseline to Week 8Measured during in-person visit at baseline and post-intervention.
Change in Self-Reported Physical ActivityChange from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by the self-report International Physical Activity Questionnaire (IPAQ). The measure assesses the types of intensity of physical activity that people do as part of their daily lives. All activities are converted to multiples of resting energy expenditure (MET) minutes per week. Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks.
Change in Medication AdherenceChange in score from Baseline to 8 weeks, and Baseline to 16 weeksMeasured by Self-Reported Medication Adherence (SRMA), a two-item self-report medication adherence scale measuring percentage of time (in 10% increments) patients report taking their heart medications in the past one and two weeks. Minimum: 0, Maximum:100. Change was calculated by subtracting the score at baseline from the score at 8 weeks and 16 weeks. Higher scores indicate greater levels of medication adherence.

Countries

United States

Participant flow

Pre-assignment details

In order to meet our goal of having 60 participants complete the intervention, we recruited 63 participants in order to account for 3 participants who were Lost to Follow-Up.

Participants by arm

ArmCount
Positive Psychology + Motivational Interviewing
Participants will complete weekly positive psychology exercises and will systematically set goals related to physical activity. Study trainers will review the positive psychology exercises on the phone each week and will use motivational interviewing techniques to facilitate goal setting. Positive Psychology+Motivational Interviewing: Participants randomized to PP-MI will receive a treatment manual. For each session, a PP exercise will be described in the manual, with instruments and space to write about the exercise and its effects. Next, an MI section will outline specific MI-based topics (e.g., pros/cons, managing slips) and facilitate physical activity goal-setting. Following randomization, participants will engage in weekly, 30-minute phone calls over the next 8 weeks. Participants will independently complete PP exercises and MI-based goals between phone sessions and review them during phone sessions.
30
MI-Based Health Education Intervention
Participants will speak on the telephone each week with a study trainer. During these calls, the trainer will provide education about a health behavior related to diabetes health (physical activity, medication adherence, diet) and will use motivational interviewing techniques to facilitate the consideration of behavior change. MI-based Health Education Intervention: Each week, participants will learn about a different health behavior topic related to diabetes health. As an attentional control, this condition has a parallel structure to the experimental arm with a treatment manual, weekly assignments, and weekly calls to review assignments. Motivational interviewing topics (e.g., pros and cons of behavior change, importance and confidence of behavior change, identification of barriers and resources to change) will be presented related to each health behavior.
30
Total60

Baseline characteristics

CharacteristicPositive Psychology + Motivational InterviewingTotalMI-Based Health Education Intervention
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants60 Participants30 Participants
Age, Continuous65.3 years
STANDARD_DEVIATION 10.6
64.4 years
STANDARD_DEVIATION 10.1
63.5 years
STANDARD_DEVIATION 9.8
Anxiety5.53 score on a scale
STANDARD_DEVIATION 4.05
5.37 score on a scale
STANDARD_DEVIATION 3.86
5.20 score on a scale
STANDARD_DEVIATION 3.72
Blood Pressure (diastolic)75.73 millimeters of mercury
STANDARD_DEVIATION 14.44
72.97 millimeters of mercury
STANDARD_DEVIATION 11.92
70.2 millimeters of mercury
STANDARD_DEVIATION 8.05
Blood Pressure (systolic)142.7 millimeters of mercury
STANDARD_DEVIATION 18.75
138.07 millimeters of mercury
STANDARD_DEVIATION 16.85
133.43 millimeters of mercury
STANDARD_DEVIATION 13.48
Body Mass Index (BMI)31.57 kg/m^2
STANDARD_DEVIATION 6.24
31.97 kg/m^2
STANDARD_DEVIATION 5.99
32.38 kg/m^2
STANDARD_DEVIATION 5.81
Depression3.87 score on a scale
STANDARD_DEVIATION 2.99
3.78 score on a scale
STANDARD_DEVIATION 3.54
3.70 score on a scale
STANDARD_DEVIATION 4.07
Diabetes Self-Care3.05 score on a scale
STANDARD_DEVIATION 1.3
3.03 score on a scale
STANDARD_DEVIATION 1.31
3.02 score on a scale
STANDARD_DEVIATION 1.35
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants3 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
29 Participants57 Participants28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Hemoglobin A1c7.40 mg/dL
STANDARD_DEVIATION 1.51
7.57 mg/dL
STANDARD_DEVIATION 1.46
7.75 mg/dL
STANDARD_DEVIATION 1.41
Medication Adherence90 percentage of medication taken
STANDARD_DEVIATION 20
91 percentage of medication taken
STANDARD_DEVIATION 19
93 percentage of medication taken
STANDARD_DEVIATION 19
Moderate-Vigorous Physical Activity10.48 minutes/day
STANDARD_DEVIATION 9.09
12.85 minutes/day
STANDARD_DEVIATION 11.96
15.21 minutes/day
STANDARD_DEVIATION 14.03
Optimism23.30 score on a scale
STANDARD_DEVIATION 4.68
23.28 score on a scale
STANDARD_DEVIATION 4.83
23.27 score on a scale
STANDARD_DEVIATION 5.06
Pain-Related Disability9.30 score on a scale
STANDARD_DEVIATION 10.81
9.02 score on a scale
STANDARD_DEVIATION 11.73
8.73 score on a scale
STANDARD_DEVIATION 12.76
Perceived Social Support69.60 score on a scale
STANDARD_DEVIATION 12.46
69.70 score on a scale
STANDARD_DEVIATION 12.38
69.80 score on a scale
STANDARD_DEVIATION 12.5
Physical Activity4339 steps/day
STANDARD_DEVIATION 1324
4682 steps/day
STANDARD_DEVIATION 1980
5025 steps/day
STANDARD_DEVIATION 2446
Physical Function92.27 score on a scale
STANDARD_DEVIATION 8.12
92.68 score on a scale
STANDARD_DEVIATION 7.55
93.10 score on a scale
STANDARD_DEVIATION 7.04
Positive Affect35.00 score on a scale
STANDARD_DEVIATION 5.74
36.03 score on a scale
STANDARD_DEVIATION 7.24
37.07 score on a scale
STANDARD_DEVIATION 8.46
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants2 Participants
Race (NIH/OMB)
Black or African American
3 Participants6 Participants3 Participants
Race (NIH/OMB)
More than one race
1 Participants5 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
25 Participants46 Participants21 Participants
Resilience18.00 score on a scale
STANDARD_DEVIATION 2.38
18.02 score on a scale
STANDARD_DEVIATION 2.1
18.03 score on a scale
STANDARD_DEVIATION 1.83
Sedentary Time524.7 minutes/day
STANDARD_DEVIATION 79
533.2 minutes/day
STANDARD_DEVIATION 90.2
541.6 minutes/day
STANDARD_DEVIATION 100.7
Self-Efficacy for Exercise54.93 score on a scale
STANDARD_DEVIATION 25.21
55.78 score on a scale
STANDARD_DEVIATION 21.35
56.63 score on a scale
STANDARD_DEVIATION 17.04
Self-Reported Physical Activity1165.13 MET minutes per week
STANDARD_DEVIATION 2132.54
1091.36 MET minutes per week
STANDARD_DEVIATION 2558.28
1017.59 MET minutes per week
STANDARD_DEVIATION 2959.11
Sex: Female, Male
Female
16 Participants31 Participants15 Participants
Sex: Female, Male
Male
14 Participants29 Participants15 Participants
Weight196.47 pounds
STANDARD_DEVIATION 41.68
198.76 pounds
STANDARD_DEVIATION 41.21
201.05 pounds
STANDARD_DEVIATION 41.31

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 30
other
Total, other adverse events
5 / 305 / 30
serious
Total, serious adverse events
1 / 300 / 30

Outcome results

Primary

Number of PP-MI Sessions Completed by Participants

Measured by number of PP-MI sessions completed by participants in the PP-MI group.

Time frame: 8 weeks

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingNumber of PP-MI Sessions Completed by Participants7.4 sessions completedStandard Deviation 1.8
Secondary

Change in Anxiety

The Hospital Anxiety and Depression Scale (HADS)-anxiety subscale was be used to measure anxiety. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of anxiety.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Anxiety8 weeks-0.79 score on a scaleStandard Deviation 2.08
Positive Psychology + Motivational InterviewingChange in Anxiety16 weeks-0.27 score on a scaleStandard Deviation 2.21
MI-based Health Education InterventionChange in Anxiety8 weeks-0.73 score on a scaleStandard Deviation 2.61
MI-based Health Education InterventionChange in Anxiety16 weeks-0.57 score on a scaleStandard Deviation 3.7
Secondary

Change in Depression

The Hospital Anxiety and Depression Scale (HADS)-depression subscale was be used to measure depression. This is a well-validated scale with few somatic symptom items that can confound mood/anxiety assessment in medically-ill patients (Range: 0-21). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of depression.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Depression8 weeks-0.54 score on a scaleStandard Deviation 2.69
Positive Psychology + Motivational InterviewingChange in Depression16 weeks-0.83 score on a scaleStandard Deviation 2.7
MI-based Health Education InterventionChange in Depression8 weeks-0.97 score on a scaleStandard Deviation 2.57
MI-based Health Education InterventionChange in Depression16 weeks-0.07 score on a scaleStandard Deviation 2.69
Secondary

Change in Diabetes Self-Care

Measured by the Summary of Diabetes Self-Care Activities (SDSCA), a well-validated measure of diabetes self-management that is associated with clinical outcomes (Range: 0-7). Higher scores indicate more diabetes self-care activities.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed all follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Diabetes Self-Care8 weeks0.91 score on a scaleStandard Deviation 1
Positive Psychology + Motivational InterviewingChange in Diabetes Self-Care16 weeks0.87 score on a scaleStandard Deviation 1.16
MI-based Health Education InterventionChange in Diabetes Self-Care8 weeks0.93 score on a scaleStandard Deviation 1.08
MI-based Health Education InterventionChange in Diabetes Self-Care16 weeks1.11 score on a scaleStandard Deviation 1.21
Secondary

Change in Moderate-Vigorous Physical Activity

ActiGraph GT3X+ step counters are validated as measures of physical activity and have been used in numerous studies of physical activity in patients with medical illness. In this trial, participants will wear the accelerometer for one week at baseline, 8 weeks, and 16 weeks to assess the feasibility of doing so and to ensure adequate capture of physical activity.

Time frame: Change from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants wore the Actigraph and provided adequate data at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Moderate-Vigorous Physical Activity8 weeks15.72 minutes/dayStandard Deviation 25.07
Positive Psychology + Motivational InterviewingChange in Moderate-Vigorous Physical Activity16 weeks10.05 minutes/dayStandard Deviation 23.73
MI-based Health Education InterventionChange in Moderate-Vigorous Physical Activity8 weeks2.26 minutes/dayStandard Deviation 11.86
MI-based Health Education InterventionChange in Moderate-Vigorous Physical Activity16 weeks2.47 minutes/dayStandard Deviation 8.87
Secondary

Change in Optimism

Life Orientation Test-Revised is a well-validated 6-item instrument used to measure dispositional optimism (Range: 0-24). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of optimism.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Optimism8 weeks1.36 score on a scaleStandard Deviation 2.8
Positive Psychology + Motivational InterviewingChange in Optimism16 weeks1.03 score on a scaleStandard Deviation 2.57
MI-based Health Education InterventionChange in Optimism8 weeks1.00 score on a scaleStandard Deviation 3.02
MI-based Health Education InterventionChange in Optimism16 weeks1.61 score on a scaleStandard Deviation 3.89
Secondary

Change in Perceived Social Support

Measured by the Multidimensional Scale of Perceived Social Support (MSPSS), a scale that measures subjectively reported social support (Range: 12-84). Higher scores indicate more subjectively reported social support.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Perceived Social Support8 weeks0.68 score on a scaleStandard Deviation 6.15
Positive Psychology + Motivational InterviewingChange in Perceived Social Support16 weeks3.13 score on a scaleStandard Deviation 7.2
MI-based Health Education InterventionChange in Perceived Social Support8 weeks-1.77 score on a scaleStandard Deviation 13.57
MI-based Health Education InterventionChange in Perceived Social Support16 weeks0.36 score on a scaleStandard Deviation 9.94
Secondary

Change in Physical Activity

Measured by Actigraph accelerometer, in number of steps per day.

Time frame: Change from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants wore the Actigraph and provided adequate data.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Physical Activity8 weeks1848 steps/dayStandard Deviation 3159
Positive Psychology + Motivational InterviewingChange in Physical Activity16 weeks969 steps/dayStandard Deviation 3377
MI-based Health Education InterventionChange in Physical Activity8 weeks273 steps/dayStandard Deviation 1498
MI-based Health Education InterventionChange in Physical Activity16 weeks171 steps/dayStandard Deviation 1159
Secondary

Change in Positive Affect

The positive affect items on the Positive and Negative Affect Schedule (PANAS), a well-validated scale used in other intervention trials and in patients with medical illnesses, will be used to measure positive affect (Range: 10-50). Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks. Higher scores indicate higher levels of positive affect.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Positive Affect8 weeks3.36 score on a scaleStandard Deviation 4.98
Positive Psychology + Motivational InterviewingChange in Positive Affect16 weeks5.80 score on a scaleStandard Deviation 7.17
MI-based Health Education InterventionChange in Positive Affect8 weeks0.13 score on a scaleStandard Deviation 5.81
MI-based Health Education InterventionChange in Positive Affect16 weeks2.61 score on a scaleStandard Deviation 5.88
Secondary

Change in Resilience

Measured by the Brief Resilience Scale (BRS), a reliable scale which assesses a person's ability to recover from stress despite adversity (Range: 6-30). Higher scores indicate more resilience.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Resilience8 weeks-0.43 score on a scaleStandard Deviation 2.5
Positive Psychology + Motivational InterviewingChange in Resilience16 weeks0.37 score on a scaleStandard Deviation 2.82
MI-based Health Education InterventionChange in Resilience8 weeks-0.43 score on a scaleStandard Deviation 2.1
MI-based Health Education InterventionChange in Resilience16 weeks-0.32 score on a scaleStandard Deviation 2.72
Secondary

Change in Sedentary Time

Measured by Actigraph accelerometer, in minutes per day.

Time frame: Change from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants wore the Actigraph and provided adequate data.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Sedentary Time8 weeks-2.66 minutes/dayStandard Deviation 66.57
Positive Psychology + Motivational InterviewingChange in Sedentary Time16 weeks2.83 minutes/dayStandard Deviation 60.78
MI-based Health Education InterventionChange in Sedentary Time8 weeks-2.95 minutes/dayStandard Deviation 68.71
MI-based Health Education InterventionChange in Sedentary Time16 weeks-6.42 minutes/dayStandard Deviation 68.46
Secondary

Change in Self-Efficacy for Exercise

Measured by the Self-Efficacy for Exercise scale (SEE), a validated scale which assess self-efficacy barriers to exercise (Range: 0-90). Higher scores indicate higher efficacy expectations in relation to exercising. This was measured at Baseline, Week 8, and Week 16.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Self-Efficacy for Exercise8 weeks7.18 score on a scaleStandard Error 23.92
Positive Psychology + Motivational InterviewingChange in Self-Efficacy for Exercise16 weeks6.93 score on a scaleStandard Error 21.26
MI-based Health Education InterventionChange in Self-Efficacy for Exercise8 weeks-3.00 score on a scaleStandard Error 20.13
MI-based Health Education InterventionChange in Self-Efficacy for Exercise16 weeks-7.89 score on a scaleStandard Error 19
Secondary

Ease of MI Component

Participants in the PP-MI group will provide ratings of ease after each MI exercise, measured on a 10-point Likert scale (0=very difficult; 10=very easy). Weekly ratings were averaged to provide an overall ease of the exercises.

Time frame: Weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingEase of MI Component8.5 units on a scaleStandard Deviation 1.9
Secondary

Ease of PP Component

Participants in the PP-MI group will provide ratings of ease after each PP exercise, measured on a 10-point Likert scale (0=very difficult; 10=very easy). Weekly ratings were averaged to provide an overall ease of the exercises.

Time frame: Weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingEase of PP Component8.6 units on a scaleStandard Deviation 1.8
Secondary

Utility of MI Component

Participants in the PP-MI group will provide ratings of utility after each MI exercise, measured on a 10-point Likert scale (0=not at all helpful; 10=very helpful). Weekly utility ratings were averaged to provide an overall utility score of the exercises.

Time frame: Weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingUtility of MI Component8.6 rating out of 10Standard Deviation 2
Secondary

Utility of PP Component

Participants in the PP-MI group will provide ratings of utility after each PP exercise, measured on a 10-point Likert scale (0=not at all helpful; 10=very helpful). Weekly utility ratings were averaged to provide an overall utility score of the exercises.

Time frame: Weeks 1-8

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingUtility of PP Component8.8 units on a scaleStandard Deviation 1.5
Other Pre-specified

Change in Blood Pressure (Diastolic)

Measured during in-person visit at baseline and post-intervention.

Time frame: Change from Baseline to Week 8

Population: Not all participants attended the follow-up visit at Week 8.

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Blood Pressure (Diastolic)-1.33 millimeters of mercuryStandard Deviation 13.54
MI-based Health Education InterventionChange in Blood Pressure (Diastolic)1.86 millimeters of mercuryStandard Deviation 6.99
Other Pre-specified

Change in Blood Pressure (Systolic)

Measured during in-person visit at baseline and post-intervention.

Time frame: Change from Baseline to Week 8

Population: Not all participants attended the follow-up visit at Week 8.

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Blood Pressure (Systolic)-2.48 millimeters of mercuryStandard Deviation 16.2
MI-based Health Education InterventionChange in Blood Pressure (Systolic)0.90 millimeters of mercuryStandard Deviation 11.77
Other Pre-specified

Change in Body Mass Index (BMI)

Measured during in-person visit at baseline and post-intervention.

Time frame: Change from Baseline to Week 8

Population: Not all participants attended the follow-up visit at Week 8, and not all of those participants who did had their weight taken.

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Body Mass Index (BMI)0.04 kg/m^2Standard Deviation 0.8
MI-based Health Education InterventionChange in Body Mass Index (BMI)-0.27 kg/m^2Standard Deviation 0.99
Other Pre-specified

Change in Hemoglobin A1c

Measured during in-person visit at baseline and post-intervention.

Time frame: Change from Baseline to Week 8

Population: Not all participants attended the follow-up visit at Week 8.

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Hemoglobin A1c-0.21 mg/dLStandard Deviation 0.57
MI-based Health Education InterventionChange in Hemoglobin A1c-0.10 mg/dLStandard Deviation 1.25
Other Pre-specified

Change in Medication Adherence

Measured by Self-Reported Medication Adherence (SRMA), a two-item self-report medication adherence scale measuring percentage of time (in 10% increments) patients report taking their heart medications in the past one and two weeks. Minimum: 0, Maximum:100. Change was calculated by subtracting the score at baseline from the score at 8 weeks and 16 weeks. Higher scores indicate greater levels of medication adherence.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Medication Adherence8 weeks4 percentage of medication takenStandard Deviation 16
Positive Psychology + Motivational InterviewingChange in Medication Adherence16 weeks3 percentage of medication takenStandard Deviation 20
MI-based Health Education InterventionChange in Medication Adherence8 weeks0 percentage of medication takenStandard Deviation 15
MI-based Health Education InterventionChange in Medication Adherence16 weeks1 percentage of medication takenStandard Deviation 21
Other Pre-specified

Change in Pain-Related Disability

Measured by the Pain Disability Index (PDI), a well-validated measure of the extent to which pain interferes with different daily activities (Range 0-70). Higher scores indicate greater interference from pain.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Pain-Related Disability8 weeks-1.36 score on a scaleStandard Deviation 12.1
Positive Psychology + Motivational InterviewingChange in Pain-Related Disability16 weeks-2.83 score on a scaleStandard Deviation 11.47
MI-based Health Education InterventionChange in Pain-Related Disability8 weeks-1.27 score on a scaleStandard Deviation 13.57
MI-based Health Education InterventionChange in Pain-Related Disability16 weeks-1.00 score on a scaleStandard Deviation 8.55
Other Pre-specified

Change in Physical Function

Measured by the 20-item short form of the Patient-Reported Outcomes Measurement Information System (PROMIS), a well-validated measure of physical function that is highly responsive to changes in a patient's physical function status (Range: 20-100). Higher scores indicate better physical function.

Time frame: Change in score from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Physical Function8 weeks0.46 score on a scaleStandard Deviation 5.3
Positive Psychology + Motivational InterviewingChange in Physical Function16 weeks2.83 score on a scaleStandard Deviation 5.95
MI-based Health Education InterventionChange in Physical Function8 weeks2.03 score on a scaleStandard Deviation 3.91
MI-based Health Education InterventionChange in Physical Function16 weeks1.93 score on a scaleStandard Deviation 4.85
Other Pre-specified

Change in Self-Reported Physical Activity

Measured by the self-report International Physical Activity Questionnaire (IPAQ). The measure assesses the types of intensity of physical activity that people do as part of their daily lives. All activities are converted to multiples of resting energy expenditure (MET) minutes per week. Change was calculated by subtracting the score at baseline from the score at 8 and 16 weeks.

Time frame: Change from Baseline to 8 weeks, and Baseline to 16 weeks

Population: Not all participants completed all follow-up questionnaires at both follow-up time points.

ArmMeasureGroupValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Self-Reported Physical Activity8 weeks1130.56 MET minutes per weekStandard Deviation 2737.04
Positive Psychology + Motivational InterviewingChange in Self-Reported Physical Activity16 weeks799.04 MET minutes per weekStandard Deviation 2753.9
MI-based Health Education InterventionChange in Self-Reported Physical Activity8 weeks606.29 MET minutes per weekStandard Deviation 4098.38
MI-based Health Education InterventionChange in Self-Reported Physical Activity16 weeks1090.85 MET minutes per weekStandard Deviation 1544.04
Other Pre-specified

Change in Weight

Measured during in-person visit at baseline and post-intervention.

Time frame: Change from Baseline to Week 8

Population: Not all participants attended the follow-up visit at Week 8, and not all of those participants who did had their weight taken.

ArmMeasureValue (MEAN)Dispersion
Positive Psychology + Motivational InterviewingChange in Weight-1.10 poundsStandard Deviation 4.91
MI-based Health Education InterventionChange in Weight-1.43 poundsStandard Deviation 5.78

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026